Stage and receptor status can indicate a breast cancer survivor’s risk of recurrence

New research indicates that for patients with breast cancer, the cancer’s stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment. The findings are published by in the journal Cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *